KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q2 2021 Results - Earnings Call Transcript

Karyopharm Therapeutics Inc. (KPTI) Q2 2021 Earnings Conference Call August 5, 2021 8:30 AM ET Company Participants Joe Rayne - Argot Partners Richard Paulson - President & Chief Executive Officer Sohanya Cheng - Senior Vice President-Sales & Commercial Operations Jatin Shah - Chief Medical Officer Mike Mason - Chief Financial Officer Conference Call Participants Brian Abrams - RBC Capital Markets Peter Lawson - Barclays David Lebowitz - Morgan Stanley Eric Joseph - JPMorgan Jonathan Chang - SVB Leerink Colleen Kusy - Baird Presentation Operator Good morning. My name is Karen, and I will be your conference operator today. At this time, I’d like to welcome everyone to Karyopharm Therapeutics' Second Quarter 2021 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advice that this call is being recorded at the company's request. I would now like to turn the call over to Joe Rayne from

For further details see:

Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q2 2021 Results - Earnings Call Transcript